Your browser doesn't support javascript.
loading
Knowledge, Attitudes, and Perceptions of Skin Cancer Clinical Trials in the Hispanic Population.
Andrade, Luis F; Lalama, Maria J; Choragudi, Siri; Maisonet, Jezabel; Ayala, Juan; Figueroa, Cesar; Lopez, Liz C; Tavarez, Lauren; Kirsner, Robert S; Strasswimmer, John.
Afiliación
  • Andrade LF; Dermatology, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, USA.
  • Lalama MJ; Medicine, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, USA.
  • Choragudi S; Medicine, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, USA.
  • Maisonet J; Dermatology, Caridad Center, Boynton Beach, USA.
  • Ayala J; Dermatology, Caridad Center, Boynton Beach, USA.
  • Figueroa C; Internal Medicine, Cesar Figueroa Clinic, Delray Beach, USA.
  • Lopez LC; Dermatology, Florida Atlantic University, Boca Raton, USA.
  • Tavarez L; Dermatology, Florida Atlantic University, Boca Raton, USA.
  • Kirsner RS; Dermatology, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, USA.
  • Strasswimmer J; Dermatology, Florida Atlantic University, Boca Raton, USA.
Cureus ; 16(4): e57480, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38707098
ABSTRACT

OBJECTIVE:

To determine the factors that might limit Hispanic patients from participating in dermatological clinical trials.

METHODS:

From January 2022 to July 2022, we administered a 31-item, in-person questionnaire to patients recruited in the waiting area of the Caridad Center, one of the largest free clinics in the United States with a predominately Hispanic population, and a nearby private primary care clinic.

RESULTS:

Overall, Hispanic patients agreed significantly more with statements in the domain of attitude and behavioral beliefs compared to non-Hispanic survey respondents. The Hispanic ethnicity was associated with increased odds of agreeing with the following statements "My community would really benefit from skin cancer clinical trials" (OR=0.52; 95% CI 0.30, 0.92), "My participation in a skin cancer study would be very good" (OR=0.59; 95% CI 0.35, 0.99), and "I like to do good for others" (OR=0.41; 95% CI 0.22, 0.77).

CONCLUSION:

While the United States population is composed of 18.5% Hispanics, they only account for 1% of patients enrolled in clinical trials. This study helps identify potential motivational factors for Hispanic patients to participate in skin cancer clinical trials.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos